← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-10 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
ADCBiologicstaleBioNTech SEPhase 1

BNT116 (BNT116)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 1

BNT316 (BNT316)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 2

BNT3212 (BNT3212)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 2

BNT323 (BNT323)

Locally Advanced Breast Cancer; Unresectable Breast Carcinoma · Locally Advanced Breast Cancer

#LocallyAdvancedBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 3

BNT323/DB-1303 (BNT323/DB-1303)

Endometrial Cancer · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 2

BNT329 (BNT329)

Advanced Solid Cancers · Advanced Solid Cancers

#AdvancedSolidCancers#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleHighlight TherapeuticsPhase 2

pembrolizumab (Keytruda, BO-112 with pembrolizumab)

Colorectal Cancer; Gastric Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 0%임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 1

bendamustine, rituximab, ibrutinib (BR-I, BR-I (bendamustine, rituximab, ibrutinib))

Mantle Cell Lymphoma; Lymphoma · Mantle Cell Lymphoma

#MantleCellLymphoma#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
ADCBiologicstaleLei ZhengPhase 1

BSI-082 (BSI-082)

Solid Tumor; Advanced Solid Tumor · Solid Tumor

#SolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
CGTBiologicstaleBioceltech Therapeutics, Ltd.Phase 1

BT-007 CD7 CAR-T cells (BT-007 CD7 CAR-T cells)

T Cell Lymphoblastic Lymphoma · T Cell Lymphoblastic Lymphoma

#TCellLymphoblasticLymphoma#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
ADCBiologicstaleThe First Affiliated Hospital w…Phase 2

BV+R-CHP (BV+R-CHP)

EBV-Positive Diffuse Large B-Cell Lymphoma, Nos; Brentuximab Vedotin · EBV-Positive Diffuse Large B-Cell Lympho

#EBV-PositiveDiffuseLargeB-CellLy#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
AntibodystaleBioXcel Therapeutics IncPhase 2

pembrolizumab (Keytruda, BXCL701 plus Pembrolizumab)

Prostate Cancer; Neuroendocrine Tumors · Prostate Cancer

#ProstateCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
ADCBiologicstaleByondis B.V.Phase 1

BYON3521 (BYON3521)

Solid Tumor · Solid Tumor

#SolidTumor#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
AntibodystaleByondis B.V.Phase 1

pembrolizumab (Keytruda, BYON4228 + Pembrolizumab)

Solid Tumor · Solid Tumor

#SolidTumor#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
ADCBiologicstaleByondis B.V.Phase 1

BYON4413 (BYON4413)

Relapsed / Refractory AML; Relapsed / Refractory MDS · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
AntibodystaleYuan YuanPhase 2

Balstilmab (Balstilmab)

Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Triple-Negative Breast Carcinoma · Anatomic Stage IV Breast Cancer AJCC v8

#AnatomicStageIVBreastCancerAJCCv#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli Lilly and CompanyPhase 2

Bamlanivimab (Bamlanivimab)

COVID-19 · COVID-19

#COVID-19#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleBayerPhase 1

BAY1905254 (Bapotulimab, Bapotulimab (BAY1905254))

Advanced Solid Tumor; Head and Neck Squamous Cell Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleMerckPhase 1

pembrolizumab (Keytruda, BAY1905254, Bapotulimab, Bapotulimab (BAY1905254) + Pembrolizumab (KEYTRUDA®))

Advanced Solid Tumor; Head and Neck Squamous Cell Carcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleNovartisPhase 3

Simulect (Basiliximab, Basiliximab (Simulect))

Organ Transplantation, Renal Transplantation · Organ Transplantation, Renal Transplanta

#OrganTransplantationRenalTranspl#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 ACTIVE

92 / 209 페이지

← 이전다음 →